Investing Ideas
/
Finnish Pharmaceuticals & Biotech High Insider Buying

Finnish Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Herantis Pharma Oyj

Market Cap: €55.9m

A clinical stage biotechnology company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD).

HRTIS

€2.11

19.2%

55.1%